electroCore, Inc.

ECOR ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-14.0M $-11.9M $-18.8M $-22.2M $-17.2M $-23.5M $-45.1M $-55.8M
Depreciation & Amortization $501.0K $760.0K $962.0K $548.0K $382.0K $399.2K $249.6K $66.7K
Depreciation $108.5K $66.7K
Amortization
Stock-Based Compensation $1.9M $1.9M $1.7M $2.7M $3.3M $3.3M $3.9M $7.6M
Net Cash from Operating Activities $-8.2M $-6.9M $-14.7M $-16.6M $-13.6M $-20.1M $-45.1M $-47.1M
Investing Activities
Capital Expenditures $66.0K $206.0K $69.7K $278.9K
Business Acquisitions
Net Cash from Investing Activities $3.9M $-8.5M $-206.0K $18.2M $-8.0M $51.0M $-36.8M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $7.6M $8.4M $7.5M $25.7M $18.9M $160.8K $78.3M
Net Change in Cash $-6.9M $-7.4M $-16.7M $30.4M $-9.3M $6.0M $-5.6M
Free Cash Flow $-8.3M $-14.9M $-45.1M $-47.4M
← Newer Page 1 of 2 Older →